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Abstract: Pseudomonas aeruginosa PAO1 has an integrated Pf4 prophage in its genome, encoding a
relatively well-characterized filamentous phage, which contributes to the bacterial biofilm organization
and maturation. Pf4 variants are considered as superinfectives when they can re-infect and kill the
prophage-carrying host. Herein, the response of P. aeruginosa H103 to Pf4 variant infection was
investigated. This phage variant caused partial lysis of the bacterial population and modulated
H103 physiology. We show by confocal laser scanning microscopy that a Pf4 variant-infection altered
P. aeruginosa H103 biofilm architecture either in static or dynamic conditions. Interestingly, in the
latter condition, numerous cells displayed a filamentous morphology, suggesting a link between this
phenotype and flow-related forces. In addition, Pf4 variant-infection resulted in cell envelope stress
response, mostly mediated by the AlgU and SigX extracytoplasmic function sigma factors (ECFσ).
AlgU and SigX involvement may account, at least partly, for the enhanced expression level of genes
involved in the biosynthesis pathways of two matrix exopolysaccharides (Pel and alginates) and
bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) metabolism.
Keywords: Pseudomonas aeruginosa; Pf4 phage variant; SigX; AlgU; cell envelope; biofilm; c-di-GMP;
membrane fluidity; cell wall stress response
1. Introduction
Pseudomonas aeruginosa is a ubiquitous Gram-negative γ proteobacterium that thrives in different
environments, including soils, water, nematodes, plants and mammals [1,2]. This opportunistic
pathogen is responsible for a wide range of infections in the lungs, urinary tract, and burn wounds [3]
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P. aeruginosa can form multi-cellular matrix-enclosed biofilms [4] that protect cells from phagocytosis [5]
and contribute to antibiotics resistance, and its persistence in lung infections [6].
Filamentous phages (Inoviridae) are widespread in the microbial world. They have a long and
thin filamentous shape and contain a single-stranded circular DNA genome [7,8]. In Gram-negative
bacteria, inoviruses are thought to be mostly lysogens with the phage genome either integrated into
the bacterial chromosome or being present as an extrachromosomal episome [7]. P. aeruginosa strains
integrate in their genome several filamentous bacteriophages designated as Pf phages. P. aeruginosa
PAO1 contains only Pf4. Phage Pf4 is closely related to Pf5 of P. aeruginosa PA14, and to a lesser extent
to Pf1 of PAK strain [7]. While Pf4 and Pf5 are maintained as prophages, Pf1 replicates exclusively
as an episome [9]. The pathway of infection of different bacteria by filamentous bacteriophages is
conserved through binding to a host-specific pilin receptor [10]. Hence, bacteriophages Pf1 and Pf4 use
as receptors type IV pili (TFP) from PAK [11] and PAO1 [12,13], respectively, while Pf3 of strain PAO
binds to the RP4 conjugative pilus [11].
Clinical data show that Pf phages are produced by P. aeruginosa isolates from sputum of cystic
fibrosis (CF) suffering patients [14–16] at an average 107 copies of Pf phage.mL−1 sputum [17,18].
Increasing amounts of evidence suggest that filamentous phages can strongly affect biofilm maturation
and dispersal [14,19]. Pf4 was indeed shown to be involved in matrix structuration [17], and to increase
cell lysis leading to extracellular DNA (eDNA) release into biofilm matrix [14,20–22]. In addition,
Pf4 infection can lead to the emergence of small colony variants [14,18]. Deletion of the whole
prophage genomic region results in less-stable biofilm when challenged with the sodium dodecyl
sulfate detergent [19]. Pf4 genes are among the most highly induced during biofilm formation compared
to planktonic growth. The same genes were found upregulated under anaerobic growth condition
at pH 6.5 in the presence of nitrate or nitrite as electron acceptors [16,20]. Pf4 proteins were also
overproduced in response to solid surface attachment [23]. Interestingly, biofilm maturation is related
to the conversion of Pf4 phage into a superinfective variant [24]. While the lysogenic P. aeruginosa
PAO1 strain carrying the Pf4 prophage integrated into its chromosome is resistant to Pf4 phage
infection [19], the same lysogenic P. aeruginosa strain becomes relatively sensitive to an infection by
the superinfective variant phage, which can partly lyse the prophage-carrying host [25]. Noticeably,
this Pf4 variant is characterized by several mutations, which are mostly located within or upstream
of repC, a Pf4-encoded repressor involved in the active life cycle of the phage [13], recently renamed
pf4r [26]. Such mutations have been suggested to result from DNA lesions in response to reactive oxygen
or nitrogen species accumulation during growth in biofilm [24]. Moreover, it has been demonstrated
that the OxyR oxidative stress response regulator binds to a region overlapping the pf4r open reading
frame [24,27]. Accordingly, the oxidative stress response mediated by OxyR has been correlated to the
superinfective variant phage emergence in biofilm [24]. In addition, Pf4 superinfection would also
be observed when a high titer of wild-type Pf4 overwhelm superinfection exclusion mechanism in
P. aeruginosa PAO1 [28].
In P. aeruginosa, cell wall integrity alterations induce a cell envelope stress response (CESR),
which reprograms gene expression to ensure bacterial survival via two extracytoplasmic function
(ECF) σ factors, AlgU and SigX [29]. AlgU is homologous to the Escherichia coli RpoE CESR σ
factor that is mainly involved in outer membrane and peptidoglycan homeostasis [30,31]. AlgU is
activated in response to hyperosmolarity [32], peptidoglycan synthesis alterations [30,31] or cell wall
perturbations related to absence of the major porin OprF [33]. Expression of oprF is controlled by
AlgU [34] and SigX [35,36], and a mutant lacking OprF shows increased expression and activity of
SigX in addition to AlgU [33]. SigX is activated in response to hypo-osmolarity [35,37], high sucrose
concentration [38], cold-shock condition or valinomycin treatment [39]. As SigX is involved in
de novo fatty acid biosynthesis [40,41], SigX activity affects membrane homeostasis [37,42,43] and
membrane fluidity [29,40,41]. In addition to their role in maintaining P. aeruginosa peptidoglycan
and membrane homeostasis, AlgU and SigX are also involved in motility, biofilm formation and
virulence [29]. This study aims to obtain further insights into the physiology of P. aeruginosa H103
Microorganisms 2020, 8, 1700 3 of 20
(the PAO1 strain originating from Hancock’s laboratory [44] after infection by a Pf4 filamentous phage
variant, using combined phenotypic and gene expression analyses.
2. Materials and Methods
2.1. Pf4 Phage Variant Production
A library of P. aeruginosa H103 mutants was created by random transposon mutagenesis to
study the transcriptional regulation of sigX (data not shown). The mini-CTX-lux plasmid with the
promoter region of sigX was integrated into the attB site in P. aeruginosa H103 resulting in dH103 strain
(Supplementary Table S1). The screening of the library allowed the identification of dH103Pf4+ mutant
(Supplementary Table S1), which displayed a partial cell lysis phenotype and overproduced Pf4 phage
variant that were named Pf4* in the following sections. To obtain Pf4* phages, the mutant dH103Pf4+
was grown for 24 h at 37 ◦C, then, 1 mL of the planktonic culture was harvested and centrifuged at
8000× g for 5 min. The supernatant was then filtered using a 0.22 µm pore size filter and stored at 4 ◦C
until further use.
2.2. Bacterial Strains, Media, and Growth Conditions
Bacterial strains used in this study are listed in Supplementary Table S1. For planktonic cultures,
bacteria were inoculated in LB medium containing 50 mM NaCl at an initial absorbance at 580 nm
(A580 nm) of 0.08. To perform RNA extraction, bis-(3′-5′)-cyclic dimeric guanosine monophosphate
(c-di-GMP) and anisotropy assays, bacteria were grown at 37 ◦C with orbital shaking at 180 r.p.m
for 5 h (wild-type) or 7 h (Pf4*-T) to reach an A580 nm~2.8. For infection experiments, supernatant of
dH103Pf4+ containing Pf4 phage variants, and lytic LUZ19 phages [45], were added to the planktonic
cultures at 1.5 × 109 phages.mL−1 (final concentration). Supernatant containing Pf4* phages was
added at the beginning of the cultures (A580nm = 0.08) for all experiments and LUZ19 phages,
when used to observe cell killing, were added at the middle of exponential growth (A580 nm = 0.5).
For co-infection experiments, supernatant containing Pf4 phage variants was added at the beginning of
the culture (A580 nm = 0.08), and LUZ19 phages were added after 3 h of growth (end of the exponential
growth (A580 nm = 2)) in order to saturate Pf4* receptors of H103. All experiments were performed
independently at least four times.
2.3. Numeration of Pf4* Phages by Double Agar Overlay Plaque Assay
The double agar overlay plaque assay was performed as previously described [46] with some
modifications. Briefly, the bottom agar was prepared by adding 15 g.L−1 technical agar (Becton Dickinson,
Franklin Lakes, NJ, USA) to LB broth medium, sterilized and dispensed in Petri dish plates. The top
agar was prepared by dissolving 6 g.L−1 noble agar (Becton Dickinson, Franklin Lakes, NJ, USA) in
distilled water, sterilized and kept at 60 ºC in a water bath. Pf4* phages from the supernatant were
diluted by tenfold serial dilution in LB broth medium. Then, 10 µL of each dilution and planktonic
cultures used as receptor strains (H103 or PAK) adjusted at A580 nm = 0.1 were added to 5 mL of top agar.
The overlay mixture was next dispensed on the bottom agar and the plates were incubated at 37 ◦C for
24 h. A supernatant stock solution obtained from planktonic cultures of H103 strain following the same
protocol as described above (see Pf4* phages production section) was used as a control condition.
2.4. Quantitative Reverse-Transcription Real-Time PCR (RT-qPCR) Analyses
Total RNAs were extracted from phage-infected P. aeruginosa cultures using the hot acid-phenol
method [35]. Genomic DNA contamination was removed by using rigorous treatment with RNAse-free
Turbo DNaseI kit (Invitrogen, Carlsbad, CA, USA), following manufacturer’s instructions. The concentration
of RNAs was determined using the NanoDrop ND-2000 spectrophotometer (ThermoFisher Scientific,
Waltham, MA, USA) and their quality was checked on an agarose gel (2%). RNAs were converted to
cDNA by the High-Capacity cDNA Reverse Transcription kits (Applied Biosystems, Foster City, CA, USA),
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according to manufacturer’s recommendations. Quantitative PCR reactions were carried out using SYBR
Green PCR Master Mix™ 335 (Applied Biosystems, Foster City, CA, USA) in an ABI 7500 Fast Q-PCR system
(Applied Biosystems, Foster City, CA, USA). All primers used in this study were designed with Primer3 plus
software (Supplementary Table S2) and were chemically synthesized and purified by Eurogentec (Liège,
Belgium). The mRNAs expression levels were normalized on 16 S rRNA threshold cycle (Ct) values
and calculated by comparing the Ct of targeted genes with those of control sample groups. The relative
quantification data were determined with the 2−∆∆Ct method using Microsoft Excel-based spreadsheet.
2.5. Twitching Motility
Planktonic cultures of H103 treated or untreated with Pf4* phage in LB medium were assayed for
twitching motility. An aliquot of 5 µL diluted to an A580 nm of 0.1 was used to inoculate the semi-solid
LB medium agar plates (1% agar w/v) underneath the agar layer. After 48 h of incubation at 37 ◦C,
the agar was removed and the bacterial cells that adhered to the Petri dish were directly stained with
0.4% crystal violet for 15 min and washed with distilled water, as previously described [43]. Then,
representative pictures were taken.
2.6. Biofilm Culture
Biofilm formation under static conditions was performed in 24-well plates with flat glass bottoms
(Greiner Bio-One, Kremsmünster, Austria). Bacterial cells of H103 strain were harvested from overnight
cultures by centrifugation (7500× g, 5 min) and washed twice with sterile physiological solution
(9 g.L−1 NaCl). Prior to biofilm formation, an adhesion step was carried out by inoculating each well
with a bacterial suspension adjusted to an A580 nm of 0.1 in sterile physiological solution for 2 h at 37 ◦C.
Non-adhered planktonic cells were then removed and LB medium at 50 mM NaCl with or without
Pf4* phages was added and biofilm cultures were grown at 37 ◦C for 22 h. Biofilms were washed
twice by sterile physiological solution. Biofilm formation was also examined under hydrodynamic
conditions, as described by Rodrigues and colleagues [47], in a three-channel flow cell with individual
channel dimensions of 1 mm × 4 mm × 40 mm (Biocentrum, Kraków, Malopolskie, Poland) [48],
using a microscope glass coverslip (24 × 50 Knittel Glass, Varrentrappstraße, Braunschweig, Germany)
as a substratum. The flow system was prepared and sterilized as previously described [49]. Briefly,
sterilization was performed by 0.5% sodium hypochlorite for 30 min and rinsed overnight by sterile
physiological solution using a 250 S Watson Marlow peristaltic pump. Bacteria were harvested from
overnight culture by centrifugation (7500× g, 5 min), washed twice with sterile physiological solution
and adjusted at A580 nm = 0.1. Bacteria were allowed to adhere for 2 h at 37 ◦C without flow. Then,
LB medium at 50 mM NaCl with or without Pf4* phages was pumped with a 2.5 mL.h−1 flow for 22 h
at 37 ◦C.
2.7. Confocal Laser Scanning Microscopy (CLSM)
Prior to CLSM examination, bacteria were stained with 5 µM of SYTO9 Green 5 dye (Invitrogen,
Carlsbad, CA, USA) for 15 min. Static biofilms were then washed twice with sterile physiological solution
and dynamic biofilms were rinsed for an additional 10 min with a flow of medium. Biofilms were
observed with a Zeiss LSM710 microscope (Carl Zeiss Microscopy, Oberkochen, Germany) using a 40× oil
immersion objective. SYTO9 was excited at 488 nm and fluorescence emission was detected from 500 to
550 nm. Images were recorded every micrometer, visualized, and processed using the Zen 2.1 SP1 software
(Carl Zeiss Microscopy, Oberkochen, Germany). Quantitative analyses of 3D images (thicknesses and
biovolumes) were performed using COMSTAT2 software (http://www.imageanalysis.dk/) [50,51]. At least
three image stacks from each of four independent experiments (twelve stacks in total) were used for
each analysis.
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2.8. Transmission Electron Microscopy (TEM)
Pf4* phages were resuspended in PBS and a drop of suspension was placed on a petri dish.
A Formvar EM grid was placed Formvar side down on top of the phages drop for approximately 1 min.
The grid was removed, blotted with filter paper, and placed onto a drop of 7.0% uranyl acetate in
distilled water for 3 min. The grid was washed in water, blotted again with filter paper, and examined
on EM JEOL 1010 at 80 KV. The pictures were recorded by using Quemesa, the electron digital camera
of Olympus.
2.9. c-di-GMP Quantification
c-di-GMP levels were quantified by LC-MS/MS as previously described [33,52]. H103 cells treated
or untreated by Pf4* phage (Pf4*-T) were harvested, centrifuged (8000× g, 2 min, 4 ◦C), and washed
in sterile physiological solution (0.9 g.L−1 NaCl). Then, bacterial pellets were resuspended in the
extraction buffer (acetonitrile/methanol/ultrapure water (2V/2V/1V)) and incubated for 15 min on
ice. Next, bacteria were lysed at 95 ◦C for 10 min and centrifuged at 20,000× g for 5 min at 4 ◦C.
The supernatants were conserved on ice and the extraction was repeated twice. All supernatants were
pooled together and evaporated at 43 ◦C for 24 h. After resuspension in 400 µL of ultrapure water,
the samples were subjected to direct quantification by LC-MS/MS. The chromatographic separation
was performed on a 1100 Series HPLC system (Agilent, Waldbronn, Germany) using a Multospher
AQ RP18, 5 µm, 250 mm × 4.0 mm HPLC column (CS Chromatography Service GmbH, Langerwehe,
Germany) in a gradient mode using methanol as eluent A and 10 mM ammonium acetate and 0.1%
acetic acid in ultrapure water as eluent B. The injection volume of each sample and the flow rate
were set at 40 µL and 0.40 mL.min−1, respectively. The gradient program was as follows: from 0 to
4 min 100% B, followed by a linear gradient from 100 to 80% B in 22 min, held for 2 min at 80% B,
followed by a linear gradient from 80 to 60% B in 1 min and held for an additional 9 min at 60%
B. Finally, re-equilibration of the column was obtained by constantly running 100% B for 16 min.
Electrospray ionization (ESI) MS was performed on an API 4000 triple quadrupole mass spectrometer
(Applied Biosystems, Toronto, ON, Canada) using a turbo ion spray interface in positive mode at
an ionization potential of 4800 V and a temperature of 450 ◦C. Nitrogen gas was used as curtain,
nebulizer, heater and collision gas. The parameter settings were optimized by infusion experiments.
Data were acquired in multiple reaction monitoring modes (MRM) using the Analyst software version
1.6.3 (Applied Biosystems, Toronto, ON, Canada). Identification and quantification of c-di-GMP were
performed by using three specific mass transitions from molecule ion m/z 691 to the product ions 152,
135, and m/z 540. The external calibration was carried out at c-di-GMP concentrations ranging from
1 to 100 ng.mL−1 (ultrapure water), analyzed in duplicate.
2.10. Membrane Fluidity Assays by Fluorescence Anisotropy
Fluorescence anisotropy measurements were performed as previously described [41,53]. P. aeruginosa
H103 cells treated or untreated with Pf4* phage (Pf4*-T) were harvested by centrifugation (8000× g),
washed twice in sterile Tris/HCl buffer (15 mM, pH 7), and resuspended in the same buffer to reach an
A580 nm = 0.2. Then, 1 µL of a 4 mM of 1,6-diphenyl-1,3,5-hexatriene (DPH, Sigma Aldrich, Saint-Louis,
MI, USA) stock solution in tetrahydrofuran was added to 1 mL aliquot of the resuspended cells and
incubated in the dark for 30 min at 37 ◦C to allow the probe to incorporate into the cytoplasmic membrane.
Further, anisotropy measurements were performed using the Spark® 20 M multimode microplate reader
(Tecan, Männedorf, Switzerland), equipped with an active temperature regulation system. Excitation and
emission wavelengths were set at 365 and 425 nm, respectively, with a gain of 95. The G correlation factor
was calculated as the relation between the horizontal and vertical emitted light after the excitation by a
horizontal light. In our conditions, the G factor was determined to 1.596. The anisotropy was calculated
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from emission fluorescence intensity measured alongside (I1) and perpendicularly (I2) to light excitation
plan, according to the equation:
r =
(I1− I2)
(I1 + 2 GI2)
The relationship between anisotropy and membrane fluidity is an inverse one, where decreasing
anisotropy values correspond to a more fluid membrane and vice versa.
2.11. Pf4 Prophage Region Sequencing
Bacterial DNA was extracted from dH103Pf4+ and H103 overnight cultures using GeneJet Genomic
DNA extraction kit (ThermoScientific, Waltham, MA, USA). A genomic library for whole genome
sequencing was prepared using the NexteraTM XT DNA library prep kit (Illumina, San Diego, California,
USA). Sequencing was performed on an Illumina MiSeq platform (LMSM Evreux, Rouen Normandy
University, France) using a paired-end protocol (2× 250 bp). Raw paired-end reads were trimmed using
Trimmomatic v.0.36 [54]. Sequence data quality was checked using FastQC v.0.11.6 [55]. Assembly of
trimmed paired-end reads was done de novo using Unicycler v.0.4.7 [56]. The obtained draft was
checked for consistency, e.g., the number of contigs, G + C content and total size of assembly,
using Quast v.5.0.0 [57]. The extracted phage sequence from P. aeruginosa PAO1 (Genbank accession
number: GCA_000006765.1) was mapped to the trimmed raw reads with BBmap v38.69 from BBTools
package [58]. Mapped reads in SAM format were converted into fastq files using SamToFastq command
in Picard (https://broadinstitute.github.io/picard/). The obtained reads covering the phage region were
mapped to PAO1 and H103 reference genomes using Snippy v.4.3.6 (https://github.com/tseemann/
snippy) to detect SNPs or deletions, and assembled into contigs as described above. Default parameters
were used except where otherwise noted.
2.12. Promoter Research
Promoters upstream of the mreB gene were predicted with BPROM (www.softberry.com) and by
visual inspection, from P. aeruginosa PAO1 genome [59] (www.pseudomonas.com).
2.13. Statistical Analyses
The data were statistically analyzed using two-samples unpaired (for dH103 and dH103Pf4+
analysis) and paired two-tailed t-test to calculate p values with GraphPad Prism (GraphPad Prism
version 4.0; GraphPad Software, San Diego, CA, USA). All values are reported and plotted as means
with SEM of at least triplicate analyses for each experimental variable. NS (not significant); p > 0.05;
* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
3. Results and Discussion
3.1. Production of Superinfective Pf4 Phages Variant under Planktonic Culture Conditions
The screening of a transposon mutant library generated for another purpose (data not shown)
led to the identification of dH103Pf4+, a transposon mutant derived from dH103 (see Materials and
Methods section), displaying a colony lysis phenotype (Figure 1A). Genome sequencing of this mutant
allowed identifying PA4722, encoding a probable aminotransferase (http://www.pseudomonas.com) as
transposon insertion site. In addition, numerous mutations were identified in three genes belonging
to the Pf4 prophage encoding region (red arrows in Figure 1B, Supplementary Figure S1). Most of
these mutations are silent (Figure 1B, in blue), and include substitutions in PA0723 (coaB), PA0724 and
PA0725, as well as a deletion in PA0724. Interestingly, only a few substitutions in PA0724 led to an
amino acid change and the codon deletion resulted in one amino acid deletion (Figure 1B, in red;
Table S3). Mutations in the genomic region encoding Pf4 prophage (PA0715-PA0729) are quite common
in biofilm-grown P. aeruginosa, since these phages (qualified as superinfectives) are suggested to
contribute to biofilm development and small colony variant formation [19]. However, to date, most of
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the described mutations have been localized in the pf4r gene or in the intergenic region between pf4r
and xisF4 (both genes are located within the intergenic region between PA0716 and PA0717). While Pf4r
confers immunity to Pf4 by repressing active life cycle, xisF4 product was recently identified as an
excisionase promoting phage excision and activating phage replication, controlling the Pf4 switch
between lysogeny and Pf4 production stage [26]. Moreover, superinfective Pf4 variants are able to form
plaques on the wild-type host, which is otherwise resistant to reinfection by the non-superinfective
phages [19]. Accordingly, the Pf4 variant isolated in the current study was able to induce lysis on its
host lawns (Figure 1C) and affected the growth of its host since the generation time was increased
from 37 min for dH103 to 57 min for dH103Pf4+ (Figure 1D). A Pf4 variant titer of about 4 × 1010
PFU.mL−1 was determined after 24 h of growth, which is in agreement with a previous study [60].
Overexpression of PA0717 by more than 1000-fold in dH103Pf4+ suggests that Pf4 phage variant
overproduction might either be due to Pf4 variant multiplication/expression and/or from prophage
expression (Figure 1E). Thus, a superinfective Pf4 phage variant was obtained herein from a planktonic
and not from a biofilm culture. Since the supernatant collected from dH103Pf4+ strain might contain
R2-type pyocin, we next assayed infection of P. aeruginosa by this supernatant. Lysis plaque assay
using supernatant of dH103Pf4+ was then tested on P. aeruginosa PAK strain, which is known to be
sensitive to pyocin R2 [61] but not to Pf4 phage [62]. No lysis plaque was observed on PAK strain,
confirming the absence of R2-type pyocins in dH103Pf4+ supernatant (Figure 1F).
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dH103 and dH103Pf4+ strains. (B). Gene mapping of the coaB-PA0725 Pf4 pro hage region in dH103Pf4+
with mutations compared to H103. Silent mutations are represented in blue. Mutations and deletion
are represented in red. (C). Lysis plaque assay using supernatant of dH103 and dH103Pf4+ performed
on H103 strain. (D). Growth curves of dH103 and dH103Pf4+ ± SEM. (E). Relative mRNA levels of
PA0717 in H103 (blue bar) and dH103Pf4+ (orange bar)± SEM as determined by RT-qPCR experiments.
(F). Lysis plaque assay using supernatant of dH103Pf4+ performed on PAK strai . (G). TEM picture
of Pf4* phage. Lysis plaques, growth and RT-qPCR experiments were assayed at least four times
independently. Statistics were achieved by unpaired (two samples) two-tailed t-test. ** p < 0.01.
Since lysogenic P. aeruginosa strains are resistant to reinfection by no -su erinfective phages [19],
and because the Pf4 phage variants produced by dH103Pf4+ mutant strai displayed interesting
phenotypes, we decided to use this variant to study the effects of such phage variant infection on
P. aeruginosa H103 molecular and physiological responses. However, to date, the reasons behind the
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involvement of any mutation (including the insertion of the transposon within PA4722) in such variant
overproduction by dH103Pf4+ strain, remain unexplained, and should be explored in forthcoming
studies. Pf4 phage variant from dH103Pf4+ supernatant was thus used in the subsequent assays and
was referred to as Pf4 variant or Pf4* in the following sections.
3.2. H103 Infection by the Pf4 Variant
P. aeruginosa H103 infection was performed by adding dH103Pf4+ supernatant containing
1.5 × 109 Pf4* PFU.mL−1 (final titer) at the beginning of the bacterial culture. As shown in Figure 2A,
growth of Pf4*-treated (Pf4*-T) H103 was affected compared to H103, since the generation time was
increased from 37 min (H103) to 55 min (Pf4*-T), in line with the data observed for dH103 and dH103Pf4+
strains (compare Figures 1D and 2A). When plated on LB agar medium, Pf4*-T H103 displayed an
altered colony morphology phenotype similar to the one of the dH103Pf4+ Pf4* phage producing strain
(Figures 1A and 2B). Moreover, Pf4 phage variant was able to form lysis plaques on P. aeruginosa H103
(Figure 2C). This result was quite surprising as the Pf4 phage was previously shown to be unable to
form plaques on the wild-type PAO1 carrying the Pf4 prophage, while forming plaques only when the
prophage is deleted from the genome [19]. These data suggest that the Pf4 phage variant produced by
dH103Pf4+ can infect the wild-type strain H103 and thus resembling a superinfection. In addition,
twitching motility, which relies on functional TFP, was totally abrogated in Pf4*-T condition (Figure 2E),
in agreement with previous reports [62]. Expression of the PA0717 gene showed a huge increase of
about 20,000-fold when P. aeruginosa was infected by Pf4* (Figure 2D), suggesting an active Pf4 or Pf4*
replication in H103 strain. Thus, it is possible that the high titer of “wild-type” Pf4 (as suggested by
PA0717 expression increase) will be sufficient to overwhelm any superinfection exclusion mechanism,
as previously shown [26]. With these cautions in mind, Pf4* phage variant infection may be considered
as resembling superinfection.
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strain and Pf4*-treated H103 (Pf4*-T)± SEM. (B). Colony morphology of H103 and Pf4*-T. ( ). Lysis plaque
assay using supernata ts of H103 and Pf4*-T strains performed n H103. (D). Twitching motility of
P. aeruginosa H103 treated or untreate by Pf4* phages. (E). Relative mRNA levels of PA0717 in
H103 (green bar) and Pf4*-T (violet bar) ± SEM as determined by RT-qPCR experiments. Growth,
lysis plaques, twitching motility and RT-qPCR experiments were assayed at least four times independently.
Statistics were achieved by paired (two samples) two-tailed t-test. **** p < 0.0001.
3.3. Pf4 Variant Infection Affects Biofilm Architecture and Cell Morphology
So far, most studies have focused on mature biofilms, at least partly because such conditions
were found t produce the superinfective Pf4 form [24]. H rein, the effe t of Pf4 phage variant
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on P. aeruginosa H103 premature biofilm development was assessed using confocal laser scanning
microscopy (CLSM) under both static (Figure 3A) and dynamic (flow cell, Figure 3B) conditions after
24 h of growth. P. aeruginosa H103 biofilm grown in static conditions displayed some mushroom-like
structures (Figure 3A). Addition of Pf4* at the onset of the biofilm culture increased the number of
these structures that appeared; however, they were smaller and scattered. COMSTAT2 image analyses
indicated that Pf4*-T condition led to slightly higher maximal and average thicknesses, while the
biofilm biovolume was not strongly affected compared to H103 (Figure 3A). Under dynamic flow
conditions (2.5 mL.h−1), P. aeruginosa H103 displayed a flat and homogeneous biofilm architecture,
mainly devoid of mushroom-like structures, with maximal and average thicknesses that were lower
than when grown in static conditions (Figure 3B). COMSTAT2 image analyses indicated that only
the maximum thickness was significantly increased (data not shown) in both cases. Noticeably,
some bacteria were found to form chains, suggesting active multiplication of the resident bacteria that
remain closely associated. Since such phenotype was not observed in static conditions, one can assume
that it may result from the medium flow condition. The addition of Pf4* phage resulted in increased
biofilm biovolume and both maximal and average thickness. Moreover, the cell morphology was
strongly altered, since numerous single and extremely elongated thin cells were observed, with some
of them reaching more than 40 µm in length. These filamentous structures were mostly located
within the flat biofilm structure (Figure 3B). However, some rare microcolonies were observed,
in which bacteria were displaying conventional length (1 to 2 µm), while the cells surrounding
the mushroom-like structures were mostly extremely elongated (Figure 3C). The results indicate
that filamentation/elongated H103 cell phenotype can be associated mainly with the presence of
Pf4* phage under dynamic biofilm formation, possibly in response to general differences between
the two conditions as nutrient supply, oxygenation or flow-related forces. A similar elongated-cell
phenotype has been previously reported in response to major stresses, such as exposure to sub-minimal
inhibitory concentrations of numerous antibiotics including beta-lactams [63] or ciprofloxacin (CIP) [64].
In E. coli [65] or P. aeruginosa [66], cell filamentation resulting from exposure to CIP sub-inhibitory
concentrations was shown to be induced by the SOS response. Then, expression of recA, lexA, uvrA,
uvrC, lon and sulA, previously shown to be involved in the SOS response [64,66], was measured in
Pf4*-T condition (Figure S2). All genes were upregulated, except lon, in our conditions. Moreover,
we measured a decrease in ftsZ transcription (Figure S2), which encodes a major cytoskeletal actor
involved in cell division [67]. Altogether, these data suggest that Pf4* infection induces biofilm
formation in P. aeruginosa by altering the architecture and cell morphology leading to the filamentation
phenotype, which could be partly the result of SOS response induction.
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Figure 3. Pf4 phage variant infection leads to altered biofilm architecture and cell morphology. Side,
top and three-dimensional views of 24 h-old biofil f H103 untreate and treated with Pf4* phage
grown under static (A) and dynamic conditions (B, ) observed by confocal laser scanning microscopy
(CLSM). Cells were stained with SYTO9 green fluorescent dye. Values represent COMSTAT2 image
analyses. Results were given ± SEM of at least three independent experiments. (C) Focus on
microcolonies f the Pf4*-T biofilm grown in dynamic conditions. Each experiment was assayed at
least four times independently.
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3.4. Increased Matrix-Encoding Genes Expression and c-di-GMP Production in Response to Pf4 Variant Infection
In the P. aeruginosa PAO1 biofilm matrix, the two exopolysaccharides (EPS), Pel and Psl, form a
scaffold that structures the biofilm [68], while a third EPS, alginate, acts as a protective barrier [69].
Since it has been previously shown that biofilm architecture was closely related to the EPS produced
by P. aeruginosa [70], we evaluated the expression of the three EPS-encoding operons by RT-qPCR.
In response to Pf4* infection, expressions of pelB and algD were strongly increased by about 53.7 and
39.3-fold, respectively, while transcription of pslB was reduced by 4.5-fold (Figure 4A). It is recognized
that AmrZ and FleQ are major regulators involved in EPS production [71](Maunders and Welch,
2017). It has been shown that the alginate and motility regulator AmrZ promotes pelB and algD
transcription [72–76], while repressing pslB expression [77]. In addition, the master regulator of flagellar
motility and exopolysaccharide production, FleQ, favors pelB expression [28,78,79]. Based on all these
data, we speculated that AmrZ and FleQ expression and/or activity could be altered in the Pf4*-T
condition. Accordingly, amrZ and fleQ transcriptions were increased by 2- and 2.1-fold, respectively,
in response to Pf4* infection (Figure 4A). Thus, it is possible that the biofilm enhancement observed in
the Pf4*-T condition was partly due to AmrZ transcriptional activity on pelB, algD and pslB, and of
FleQ on pel operon. In addition, the AmrZ-repressed pilA gene [80] was strongly downregulated
(Figure 4A), in line with the reduced twitching motility (as shown in Figure 2E), comforting a possible
AmrZ activity. However, while significant, this two-fold increased expression of both amrZ and
fleQ remains modest, suggesting that other mechanisms would be involved in the observed biofilm
alterations in response to Pf4 treatment. FleQ is known to act on EPS production via its binding to the
intracellular second messenger bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) [81].
High c-di-GMP levels are correlated to increased cell aggregation, surface attachment and biofilm
formation in P. aeruginosa [82] (Romling and Galperin, 2017), via regulating expression of genes
encoding enzymes of the EPS biosynthetic pathways [25,28,79,83]. We therefore quantified c-di-GMP
level and showed that infection by Pf4* resulted in a significant increase of 27% of c-di-GMP level
(Figure 4B). Interestingly, the cdrA gene, encoding a biofilm matrix protein [84], is regulated by
c-di-GMP and its expression is therefore used as a c-di-GMP-level reporter [85]. As shown in Figure 4A,
cdrA transcription was increased by two-fold in response to Pf4* infection, supporting our finding
that c-di-GMP was overproduced in this condition. In addition, cdrA expression is regulated by
AmrZ [74,75], and FleQ that binds to c-di-GMP to promote pelA and cdrA expression [79,84]. Altogether,
these data show that P. aeruginosa H103 infection by Pf4 phage variant resulted in increased expression
of genes involved in EPS production, at least via enhanced expression and activity of AmrZ and FleQ
in the presence of high c-di-GMP level. Further assays would be required to establish a causal link
between these two master regulators and the matrix EPS production as well as the biofilm alterations
that were observed in response to Pf4* treatment.
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3.5. Pf4 Phage Variant Infection Triggers a SigX-Mediated Cell Envelope Stress Response
Since infection by Pf4 relies on attachment of phage particles on P. aeruginosa TFP and phage
extrusion occurs across the cell envelope, we hypothesize that this phage–host interaction might
trigger a cell envelope stress and thus a CESR. In P. aeruginosa, CESR relies mainly on the two ECF
σ factors AlgU and SigX [29]. To assess the involvement of SigX in P. aeruginosa response to Pf4*
infection, expression of sigX and some of its known targets (cfrX, cmpX and fabY) were evaluated
by RT-qPCR. Remarkably, expression of sigX was strongly enhanced by 5.7-fold in response to Pf4*
infection (Figure 5A). In addition, expression of the SigX targets cfrX, cmpX and fabY were increased by
23.3, 28.0 and 5.1-fold, respectively, in Pf4*-T condition (Figure 5A). Previous studies have reported
inducing conditions of sigX expression [33,35,37–39,41,43]. For instance, the absence of the major porin
OprF triggered increased sigX expression by about three-fold [33]. The exposure of P. aeruginosa to a
cold-shock condition or to a valinomycin treatment resulted in increased sigX transcription by about
two- and 7-fold, respectively [39]. Noticeably, the latter condition resulted in increased sigX expression
at levels similar to the ones observed in response to Pf4* phage treatment. Since valinomycin as well
as Pf4* treatment altered P. aeruginosa membrane fluidity, our data suggest that SigX is activated in
response to membrane alterations. SigX is furthermore involved in c-di-GMP metabolism through
PA1181, PA2072 and gcbA (PA4843) expression regulation [33,37,38,43]. As shown in Figure 5A,
PA1181 and gcbA were upregulated in Pf4*-T condition, compared to H103. Since GcbA displays
a diguanylate cyclase activity [74], while PA1181 contains both GGDEF and EAL motifs, our data
suggest that these two proteins may be involved in the increased c-di-GMP level upon Pf4* infection.
Interestingly, other growth conditions (e.g., high sucrose concentration and absence of the major porin
OprF), in which SigX is active, were also shown to affect the expression of PA1181 and gcbA [38,65],
suggesting that the CESR encountered by P. aeruginosa would be similar in these three conditions.
In addition, SigX was previously shown to be involved in pelB but not pslB expression when P. aeruginosa
was exposed to high sucrose concentration [38] or in a mutant lacking the major outer membrane protein
OprF [33]. These two conditions lead to a cell wall stress, during which SigX is activated, suggesting a
direct or indirect link between SigX activity and pel expression. Noticeably, amrZ, the product of which
positively regulates the expression of pel but not psl in P. aeruginosa PAO1 [74], was recently shown
to be part of the SigX regulon [39]. The amrZ expression was slightly increased in response to Pf4*
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infection, which correlated with SigX expression and activity. However, AmrZ was also described to
be a repressor of gcbA transcription [74]. These data suggest that SigX could bypass AmrZ-dependent
gcbA repression by a mechanism that needs to be unraveled by further studies.
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3.6. Pf4 Phage Variant Infection Induces P. aeruginosa Membrane Fluidity Alteration
SigX has also been reported to be involved in the modulation of membrane fluidity through the
regulation of fatty acid biosynthesis, which results in changes in the cell membrane phospholipid
composition in order to maintain envelope integrity [37,41,42]. To evaluate P. aeruginosa’s
membrane fluidity post Pf4* infection, fluorescence anisotropy (FA) measurements using a
1,6-diphenyl-1,3,5-hexatriene (DPH) fluorescent probe were performed. As shown in Figure 5B,
FA values decreased when P. aeruginosa was infected with Pf4 phage variant, compared to H103,
revealing increased membrane fluidity. Altogether, these data indicate that Pf4* infection increases
membrane fluidity probably because of the strong activity of SigX. Interestingly, in E. coli, the ECF
sigma factor RpoE (the AlgU homologue), the Cpx, Rcs and Bae signaling pathways, and the phage
shock protein (Psp) response mediate CESR. Remarkably, the Psp response is activated in E. coli
in response to infection by filamentous phages [86] and to treatment with the membrane stressors
verapamil and dibucaine [87]. To date, no homologous Psp response was reported in P. aeruginosa.
Our data might suggest that SigX would function in P. aeruginosa similar to the Psp response in E. coli.
3.7. Pf4 Phage Variant Infection Triggers an AlgU-Mediated Cell Envelope Stress Response
We next assayed expression and activity of the second major actor involved in P. aeruginosa CESR,
the ECF σ factor AlgU. AlgU controls a large regulon of more than 300 genes, including algU itself,
algR, amrZ, cmaX and the 12 alginate biosynthesis genes that algD is among [29,88]. Infection by Pf4*
resulted in strong expression and activity of AlgU (see Figures 4A and 6A), as was the case for SigX.
The transcriptional regulator AlgR is involved in the expression of algD as well as mucR, which encodes
for a diguanylate cyclase [89]. In the current study, we observed that mucR expression was increased
by five-fold in response to Pf4* infection, suggesting that MucR could also contribute to the increased
c-di-GMP level observed in P. aeruginosa after Pf4* infection.
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Figure 6. Pf4 phage variant infection leads to an AlgU-mediated cell envelope stress response
in H103 strain. (A). Relative mRNA expression of algU, algD, algR, cmaX, mucR and mreB in H103
(green bars) and Pf4*-T (violet bars) conditions as determined by RT-qPCR experiments. (B). Sequence of
the DNA region upstream of mreB showing a predicted AlgU-dependent promoter and σ70-dependant
promoter. (C). Relative mRNA expression levels of mreB in P. aeruginosa H103 (green bar) and ∆algU
(yellow bar) as determined by RT-qPCR experiments. Each experiment was assayed at least four
times independently. Statistics were achieved by paired (two samples) two-tailed t-test. NS p > 0.05;
** p < 0.01; *** p < 0.001; **** p < 0.0001.
Interestingly, the mreB gene, encoding an actin-like protein responsible for maintaining bacterial
shape in many bacteria [90], was previously suggested to belong to AlgU regulon [88]. By visual
inspection of the mreB upstream gene sequence, an AlgU-dependent promoter was found based on
the previously describe consensus sequence [34] (Fi ure 6B). Noticeably, mreB was overexpressed
by 13-fold in response to Pf4* treatment (Figure 6A). However, mreB transcription level was slightly,
but not significantly, decreased in an algU mutant, suggesting that AlgU was not involved or at least
that other regulator(s) are involved in mreB expression in response to Pf4* treatment (Figure 6C).
Moreover, a putative σ70-dependent promoter was found upstream of the AlgU promoter (Figure 6B),
which could explain the basal expression of mreB in the algU mutant (Figure 6C). Since overexpression
of MreB confers a filamentous phenotype, due to the inhibition of cell division [91], it is possible
that MreB could contribute to the filamentous phenotype that we observed in Pf4*-T condition
biofilms (Figure 3B). Further assays would be required to demonstrate the involvement of mreB in
the cell elongation phenotype observed in response to Pf4* infection. This first set of data raised
the question of the relationship between the membrane fluidity and the bacterial cytoskeleton.
Intriguingly, in vivo observations using specific lipid-binding dyes showed that the membrane
assembly of the actin-homologue MreB filaments with the membrane generates fluid lipid domains
and promotes movement of membrane proteins and lipids [92], similar to actin in cortical cytoskeleton
of eukaryotes [93]. In addition, MreB mis-localization induces formation of membrane invaginations
enriched in high fluidity domains [94]. Based on these data, the increased production of MreB could
generate a major stress leading to SigX hyperactivity and increased membrane fluidity. Taken together,
our study reports, for the first time, the molecular relationships between Pf4* infection and the CESR
in P. aeruginosa, involving both the two major ECF sigma factors in the bacterial response to such
stress treatment.
3.8. Does the CESR Mediated by SigX and AlgU Rely on Pf4 Phage Variant Infection?
To further confirm the involvement of SigX and AlgU in P. aeruginosa H103 response to Pf4*
infection, expression and activity of both SigX and AlgU were determined in the two ECF σ factors
deletion mutants treated by Pf4*. As expected, no differential gene expression could be observed
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when comparing Pf4*-T to non-treated mutant strains (Supplementary Figure S3A), confirming that
both SigX and AlgU are involved in the observed Pf4*-induced phenotypes. However, the signal
resulting from Pf4* infection leading to their activity is still unknown. One possibility is that both
mutants are altered in their TFP production and/or activity [43,95]. Since TFP are Pf4 receptors [12],
their absence or inactivity could explain the absence of twitching motility and Pf4*-induced lysis
plaques (Supplementary Figure S3B). To get further insights into the response to Pf4* filamentous phage
infection, we infected P. aeruginosa H103 with LUZ19, a lytic TFP-mediated phage [45]. After 20 min of
infection, corresponding to the very early entry into the lytic phase (before cell lysis, Supplementary
Figure S4A), RNAs were extracted and expression of sigX, algU and some of their targets was
investigated. Even if expression of sigX and its targets was slightly reduced when P. aeruginosa was
infected with LUZ19, no significant difference of expression or activity was observed for both ECF
σ factors (Supplementary Figure S4B), suggesting that the CESR mediated by SigX and AlgU may
specifically rely on Pf4* filamentous phage infection. In addition, when the cells were first infected
with Pf4 variant and further with LUZ19 phages, a clearly reduced lysis phenotype was observed
(Supplementary Figure S4C), as expected since the two phages are competing for the same TFP
receptors. Altogether, our data suggest that phage–host interaction via TFP is required but is not
sufficient to generate a CESR. Otherwise, it remains plausible that the CESR was not activated after
20 min of infection. Further research is required to establish the specific molecular mechanisms of TFP
activity inhibition after Pf4* phage binding and its relationship with the CESR.
4. Concluding Remarks
We show herein, for the first time, that Pf4 variant filamentous phage infection results in an
extensive CESR, mediated by the two major ECF σ factors SigX and AlgU. Our data are summarized
in Figure 7. Drastic phenotypes were observed in response to Pf4 variant infection at the cell-level,
such as increased membrane fluidity related to SigX hyperactivity, and altered cell morphology.
In addition to these important observed cellular phenotypes, Pf4 variant infection resulted also in
increased biofilm formation and c-di-GMP production, at least partly via the activity of both AlgU
and SigX. Since TFP serve as Pf4 receptors, their role in this major stress response would also deserve
further studies, which would be deciphered at least partly by a global RNA-seq analysis. Finally,
such Pf4 variant is an excellent tool to better understand the lysogenic bacteria response to phage
infection. Additional studies on dH103Pf4+ strain would be of great interest to understand the relations,
if they exist, between PA4722 mutation and Pf4 variants overproduction.
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Figure 7. Pf4 phage variant infection altered P. aeruginosa H103 regulatory circuits and physiology.
P. aeruginosa H103 infection by Pf4 phage variant leads to a SigX and AlgU-mediated cell envelope stress
response. The activation of the SigX extracytoplasmic function sigma (ECF σ) factor triggers increased
membrane fluidity and increased gene expression of gcbA and PA1181 diguanylate cyclases, most likely
responsible of the c-di-GMP-increased concentration. The AlgU activation leads to increased algR
expression, whose products are responsible for mucR increase, encoding another diguanylate cyclase.
The ECF σ factors AlgU and SigX modulate amrZ expression, which in turn controls exopolysaccharide
gene expression. The increased c-di-GMP concentration (according to cdrA gene expression) and
exopolysaccharides lead to a switch from planktonic to sessile lifestyles. The increased of mreB
expression and the induction of the SOS response could be responsible for the observed filamentation
phenotype. Thin black full arrows or broken lines represent direct transcriptional regulation. Thin blue
full arrow indicates a direct regulation, but not at the transcriptional level. Thin grey arrow represents
the possible bypass of SigX in gcbA transcriptional AmrZ-dependent regulation. Thin dashed arrow
represents potential regulation.
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